Previous Article | Next Article ![]()
J. Bacteriol., Oct 1996, 5676-5682, Vol 178, No. 19
L Petersen and DM Downs
The alternative pyrimidine biosynthetic (APB) pathway can synthesize the
4-amino-5-hydroxymethyl-2-methyl pyrimidine (HMP) moiety of thiamine in
Salmonella typhimurium independently of de novo purine biosynthesis. When
mutants defective in function of the APB pathway were isolated, the
predominant class (40%) were defective in a single locus we have designated
apbC. Mutations in apbC block function of the APB pathway since they
prevent growth of a purF mutant in the absence of thiamine. Lesions in apbC
also cause a thiamine auxotrophy in strains proficient in purine
biosynthesis when fructose is provided as the sole carbon and energy
source. Results presented here are consistent with ApbC being involved in
the conversion of aminoimidazole ribonucleotide to HMP, and we suggest that
ApbC performs a redundant step in thiamine synthesis. Sequence analysis
demonstrated that apbC mutations were alleles of mrp, a locus previously
reported in Escherichia coli as a metG-related protein. We propose that
this locus in S. typhimurium be designated apbC to reflect its involvement
in thiamine synthesis.
Copyright © 1996, American Society for Microbiology
Mutations in apbC (mrp) prevent function of the alternative pyrimidine biosynthetic pathway in Salmonella typhimurium
Department of Bacteriology, University of Wisconsin--Madison, 53706, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»